Antibody–drug conjugates: Recent advances in payloads

por Wang, Zhijia, Li, Hanxuan, Gou, Lantu, Li, Wei, Wang, Yuxi
Publicado 2023

Establishment and characterization of intraperitoneal xenograft models by co-injection of human tumor cells and extracellular matrix gel

por YAO, YUQIN, ZHOU, YONGJUN, SU, XIAOLAN, DAI, LEI, YU, LIN, DENG, HONGXIN, GOU, LANTU, YANG, JINLIANG
Publicado 2015

HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma

por Peng, Jinxia, Zhao, Ju, Zhao, Yumei, Wu, Peng, Gou, Lantu, Fu, Shaozhi, Chen, Ping, Lu, Yun, Yang, Linglin
Publicado 2020

Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling

por Chen, Xiangzheng, Wu, Yangping, Yang, Tinghan, Wei, Mingtian, Wang, Yuxi, Deng, Xiangbing, Shen, Congcong, Li, Wenting, Zhang, Hang, Xu, Weiyong, Gou, Lantu, Zeng, Yong, Zhang, Yonghui, Wang, Ziqiang, Yang, Jinliang
Publicado 2016

Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models

por Yu, Lin, Lu, Ying, Yao, Yuqin, Liu, Yu, Wang, Yuxi, Lai, Qinhuai, Zhang, Ruirui, Li, Wenting, Wang, Ruixue, Fu, Yuyin, Tao, Yiran, Yi, Shuli, Gou, Lantu, Chen, Ligong, Yang, Jinliang
Publicado 2017

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma

por Fu, Yuyin, Peng, Yujia, Zhao, Shengyan, Mou, Jun, Zeng, Lishi, Jiang, Xiaohua, Yang, Chengli, Huang, Cheng, Li, Yuyan, Lu, Yin, Wu, Mengdan, Yang, Yanfang, Kong, Ting, Lai, Qinhuai, Wu, Yangping, Yao, Yuqin, Wang, Yuxi, Gou, Lantu, Yang, Jinliang
Publicado 2021

Effective antitumor activity of 5T4‐specific CAR‐T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo

por Guo, Cuiyu, Dong, E, Lai, Qinhuai, Zhou, Shijie, Zhang, Guangbing, Wu, Mengdan, Yue, Xiaozhu, Tao, Yiran, Peng, Yujia, Ali, Jamel, Lu, Ying, Fu, Yuyin, Lai, Weirong, Zhang, Zhixiong, Ma, Fanxin, Yao, Yuqin, Gou, Lantu, Yang, Hanshuo, Yang, Jinliang
Publicado 2020

Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer

por Zhang, Hang, Wang, Yuxi, Wu, Yangping, Jiang, Xiaohua, Tao, Yiran, Yao, Yuqin, Peng, Yujia, Chen, Xiangzheng, Fu, Yuyin, Yu, Lin, Wang, Ruixue, Lai, Qinhuai, Lai, Weirong, Li, Wenting, Kang, Yuhuan, Yi, Shuli, Lu, Ying, Gou, Lantu, Wu, Min, Yang, Jinliang
Publicado 2017

Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma

por Tao, Yiran, Wang, Ruixue, Lai, Qinhuai, Wu, Mengdan, Wang, Yuxi, Jiang, Xiaohua, Zeng, Lishi, Zhou, Shijie, Li, Zhongping, Yang, Tinghan, Yao, Yuqin, Wu, Yangping, Yu, Lin, Fu, Yuyin, Lai, Weirong, Peng, Yujia, Lu, Ying, Zhang, Zhixiong, Guo, Cuiyu, Zhang, Guangbing, Gou, Lantu, Yang, Jinliang
Publicado 2019

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma

por Zhang, Guangbing, Guo, Cuiyu, Wang, Yan, Zhang, Xianda, Liu, Shuang, Qu, Wen, Chen, Chunxia, Yan, Lingli, Yang, Zhouning, Zhang, Zhixiong, Jiang, Xiaohua, Chen, Xiaofeng, Liu, Hong, Lai, Qinhuai, Wei, Xian, Lu, Ying, Zhao, Shengyan, Deng, Han, Wang, Yuxi, Yu, Lin, Yu, Hongbin, Wu, Yu, Su, Zhaoming, Chen, Pengyu, Ren, Ziqing, Yu, Meng, Qu, Feng, Luo, Yong, Gou, Lantu, Li, Qing, Huang, Ying, Ma, Fanxin, Yang, Jinliang
Publicado 2022